{"url_path":"/sec/adgm/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/2006986/0001104659-26-065180-index.html","accession_number":"0001104659-26-065180","cik":"0002006986","ticker":"ADGM","issuer_name":"Adagio Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2006986/0001104659-26-065180-index.html","primary_entity_key":"0002006986","primary_entity_name":"Adagio Medical Holdings, Inc."},"word_count":86,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit No.**\n \n**Description**\n\n[99.1](tm2614299d2_ex99-1.htm)\n \n[Press Release, dated May 21, 2026](tm2614299d2_ex99-1.htm)\n\n \n \n \n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n 2 \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\nDated: May 21, 2026\n\n \n\n \n**Adagio Medical Holdings, Inc.**\n\n \n \n\n \nBy:\n/s/ Deborah Kaster\n\n \nName:\nDeborah Kaster\n\n \nTitle:\n\nChief Financial Officer and\n\nChief Business Officer\n\n \n\n 3"}